The Senate Health Committee schedules a November 18, 2026 vote on Dr. Heidi Overton's nomination to serve as FDA commissioner. Republicans aim to confirm President Trump's nominees before losing their Senate majority in January 2027. However, panel Chair Bill Cassidy remains undecided due to broken administration promises regarding vaccine policy. Overton faces additional pressure from anti-abortion group Susan B. Anthony Pro-Life America over FDA oversight of the abortion pill mifepristone.
Overton FDA nomination vote
- ▪The Senate Health Committee scheduled a November 18, 2026 vote on James O'Neill's nomination to serve as director of the National Science Foundation alongside the vote on Dr. Heidi Overton
- ▪The Senate Health, Education, Labor, and Pensions Committee scheduled a vote on President Donald Trump's nomination of Dr. Heidi Overton to serve as commissioner of the FDA
- ▪President Donald Trump nominated Dr. Heidi Overton to serve as FDA commissioner in August 2026, following the resignation of Dr. Marty Makary in May 2026
Republican confirmation urgency
- ▪Republicans hold a single-vote majority on the Senate Health Committee, meaning a single Republican opposition vote would sink Dr. Heidi Overton's nomination if all committee Democrats vote against her
- ▪Senate Republicans are working to confirm President Donald Trump's nominees before Democrats assume control of the Senate majority in January 2027 following the midterm elections
Cassidy nomination skepticism
- ▪Senate Health Committee Chair Bill Cassidy stated on November 11, 2026, that he remains undecided on Dr. Heidi Overton's nomination to lead the FDA and noted that other committee Republicans are also undecided
- ▪Senator Bill Cassidy cited broken promises and irresponsible decisions by administration officials under HHS Secretary Robert F. Kennedy Jr. as reasons for trust issues surrounding health and science nominations
Overton vaccine policy concerns
- ▪During her September 24, 2026 confirmation hearing, Dr. Heidi Overton told senators that available vaccines are safe and effective and identified the MMR vaccine as the best tool against measles outbreaks
- ▪Senator Bill Cassidy, a physician, previously called Dr. Heidi Overton's involvement in the Trump administration's executive order to roll back childhood vaccination recommendations almost disqualifying
Mifepristone oversight stakes
- ▪If confirmed as FDA commissioner, Dr. Heidi Overton would oversee safety reviews for the abortion pill mifepristone
- ▪Anti-abortion group Susan B. Anthony Pro-Life America urged Republican senators to oppose Dr. Heidi Overton's FDA nomination unless the administration halts mail-order mifepristone and overhauls its safety review
Story comments
Loading comments…